Q3 2017 13F Holders as of 9/30/2017
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
119M
-
Number of holders
-
125
-
Total 13F shares, excl. options
-
39M
-
Shares change
-
+1.3M
-
Total reported value, excl. options
-
$565M
-
Value change
-
+$21.9M
-
Put/Call ratio
-
0.86
-
Number of buys
-
65
-
Number of sells
-
-57
-
Price
-
$14.50
Significant Holders of CYTOKINETICS INC - COMMON STOCK (CYTK) as of Q3 2017
159 filings reported holding CYTK - CYTOKINETICS INC - COMMON STOCK as of Q3 2017.
CYTOKINETICS INC - COMMON STOCK (CYTK) has 125 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 39M shares
of 119M outstanding shares and own 32.66% of the company stock.
Largest 10 shareholders include BlackRock Inc. (6.85M shares), FMR LLC (4.49M shares), VANGUARD GROUP INC (3.39M shares), JANUS HENDERSON GROUP PLC (2.78M shares), LANSDOWNE PARTNERS (UK) LLP (2.65M shares), WELLINGTON MANAGEMENT GROUP LLP (2.32M shares), STATE STREET CORP (1.84M shares), CITADEL ADVISORS LLC (1.25M shares), BVF INC/IL (1.24M shares), and PINNACLE ASSOCIATES LTD (1.01M shares).
This table shows the top 125 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.